Clinical Scorecard: Non-fluoroscopic Ablation Techniques for Right-Sided Supraventricular Tachycardia: A Comprehensive Guide and Retrospective Analysis
At a Glance
Category
Detail
Condition
Right-Sided Supraventricular Tachycardia
Key Mechanisms
Zero-fluoroscopy catheter ablation using electroanatomic mapping and intracardiac echocardiography.
Target Population
Patients with symptomatic and recurrent reentrant and focal arrhythmias.
Care Setting
Electrophysiology laboratory
Key Highlights
Zero-fluoroscopy interventions are feasible, efficient, and safe.
The prevalence of paroxysmal SVT is estimated at 332.9/100,000 individuals.
Catheter ablation is recommended as first-line treatment for symptomatic SVT.
The use of 3D electroanatomic mapping systems has reduced fluoroscopy use.
Occupational radiation exposure impacts reproductive health and fetal development.
Guideline-Based Recommendations
Diagnosis
Use of electroanatomic mapping for precise navigation and visualization.
Management
Catheter ablation as first-line treatment for symptomatic and recurrent SVT.
Monitoring & Follow-up
Evaluate procedural outcomes and monitor for complications post-ablation.
Risks
Risks associated with radiation exposure and orthopedic injuries from lead aprons.
Patient & Prescribing Data
86 consecutive patients undergoing ablation from May 2024 to April 2025.
Ablation procedures were performed using CARTO™ 3 EAM system and specific catheter types.
Clinical Best Practices
Discontinue beta-blockers and anti-arrhythmic drugs prior to the procedure.
Use ultrasound guidance for venous access to enhance procedural safety.
Employ intracardiac echocardiography for improved visualization during ablation.
Heart rate monitoring and atrial fibrillation detection had the strongest supporting evidence, but investigators found limited evidence for broader outpatient self-monitoring applications.
Federal prosecutors allege that a Florida physician and research staff fabricated clinical trial records that were submitted into database systems used to evaluate investigational drugs.
